AstraZeneca announced 500 new, high-paying jobs in Peel and the surrounding region Global pharmaceutical company, AstraZeneca announced plans to expand its research operations and create 500 skilled scientific and research jobs in Mississauga, Ontario. AstraZeneca’s investment in Ontario will help to advance the understanding of investigational compounds that may one day become life-changing medicines. This project will accelerate the development of therapeutic drugs and vaccines through the creation of a new Alexion, AstraZeneca Rare Disease Development Hub and expansion of the AstraZeneca's Research & Development Hub, which is currently spearheading global clinical studies in oncology and immunology. Ontario is home to the largest life sciences ecosystem in Canada. The province is ranked number one in the G7 for active clinical trials per capita, with the world’s top ten pharmaceutical companies by revenue conducting clinical trials in Ontario. The decision to invest in Ontario is a testament to the network of world-class universities, hospitals, and research centers in the GTA and southern-Ontario, and the diverse scientific talent pool that exists in the region. In addition, we’re pleased to see the steps the Ontario government has taken to support the sector by introducing the province’s first ever life sciences strategy, and we look forward to working with them to help improve access to new medicines for all Canadians, to ensure Ontario remains globally competitive for future research and clinical investments. – Kiersten Combs, President, AstraZeneca Canada AstraZeneca is among Canada’s leading R&D contributors across all industries, investing $135.6M in Canadian health sciences research in 2021. They are working on 174 active clinical studies involving 2,800 patients and their Ontario site is leading 100+ clinical studies worldwide. Invest Ontario, the province’s dedicated investment attraction agency, is committed to fostering innovation and growing the life sciences footprint in the province. The agency works with AstraZeneca and other stakeholders in the sector to foster investment that supports innovation and creates high-value jobs for Ontarians. Invest Ontario congratulates AstraZeneca on this significant new investment which will drive innovation and increase the capacity for the management and delivery of clinical trials in Ontario. Invest Ontario is committed to attracting investments that further accelerate the growth of life sciences and solidify our position as a global leader in the industry. – Trevor Dauphinee, CEO of Invest Ontario In 2022, Ontario launched a life sciences strategy, Taking Life Sciences to the Next Level whose goal is to maintain and grow Ontario’s biomanufacturing and life sciences sector by targeting 85,000 high-value jobs in the sector by 2030, a 25% increase from 2020.
spotlightsOntario Investment RoundupYear after year, we have seen billions in investments in the automotive, advanced manufacturing and life sciences industries in Ontario, Canada.... Press ReleaseOntario promotes growing life sciences sector during Trade Mission to BostonInvest Ontario was at BIO 2023 to promote the province’s growing life sciences and biotech sector and explore new opportunities for investment.... spotlightsTop Ontario biotech companies to watch in 2023Ontario biotechnology enterprises are impacting health and wellness globally through the province’s world-class life sciences talent and innovation.... Op EdUnleashing Innovation and Collaboration: Ontario, Canada’s Life Sciences Sector Leads the WaySenior Economic Officers Aaron Pinto and Chelsea Peet discuss Ontario’s key life sciences value propositions and what makes the province a leader in the sector.... success storiesOntario has the secret recipe for a thriving clinical trials environmentOntario has long been an attractive jurisdiction for high-quality clinical trials, but within the last decade, its activity outranks other global jurisdictions. ... spotlightsOntario, Canada ranks top 5 for FDI into North AmericaIn a world in economic flux, fDi Intelligence’s 2022 Global Greenfield Investment Trends reveals the province’s FDI investments show no sign of slowing down.... success storiesOntario biotech startup receives Gates Foundation grant to make contraceptives more accessibleOntario-based Cyclica’s new-age AI is generating more non-hormonal contraceptive choices for women in developing countries.... Press ReleaseOntario attracts economic opportunities with Trade Mission to IndiaThe Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors....
